| Original language | English |
|---|---|
| Pages (from-to) | 27-34 |
| Number of pages | 8 |
| Journal | European journal of cancer |
| Volume | 100 |
| DOIs | |
| Publication status | Published - 2018 |
Cite this
Phase I results of a phase I/II study of weekly nab-paclitaxel in paediatric patients with recurrent/refractory solid tumours: A collaboration with innovative therapies for children with cancer. / Moreno, L.; Casanova, M.; Chisholm, J.C.; Berlanga, P.; Chastagner, P.B.; Baruchel, S.; Amoroso, L.; Melcón, S.G.; Gerber, N.U.; Bisogno, G.; Fagioli, F.; Geoerger, B.; Glade Bender, J.L.; Aerts, I.; Bergeron, C.; Hingorani, P.; Elias, I.; Simcock, M.; Ferrara, S.; Le Bruchec, Y.; Slepetis, R.; Chen, N.; Vassal, G.
In: European journal of cancer, Vol. 100, 2018, p. 27-34.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Phase I results of a phase I/II study of weekly nab-paclitaxel in paediatric patients with recurrent/refractory solid tumours: A collaboration with innovative therapies for children with cancer
AU - Moreno, L.
AU - Casanova, M.
AU - Chisholm, J.C.
AU - Berlanga, P.
AU - Chastagner, P.B.
AU - Baruchel, S.
AU - Amoroso, L.
AU - Melcón, S.G.
AU - Gerber, N.U.
AU - Bisogno, G.
AU - Fagioli, F.
AU - Geoerger, B.
AU - Glade Bender, J.L.
AU - Aerts, I.
AU - Bergeron, C.
AU - Hingorani, P.
AU - Elias, I.
AU - Simcock, M.
AU - Ferrara, S.
AU - Le Bruchec, Y.
AU - Slepetis, R.
AU - Chen, N.
AU - Vassal, G.
N1 - Cited By :1 Export Date: 4 February 2019
PY - 2018
Y1 - 2018
U2 - 10.1016/j.ejca.2018.05.002
DO - 10.1016/j.ejca.2018.05.002
M3 - Article
VL - 100
SP - 27
EP - 34
JO - European Journal of Cancer
JF - European Journal of Cancer
SN - 0014-2964
ER -